title: A favourable outcome using oral prednisolone and losartan only in a patient with ANCA-related glomerulonephritis: a discrepancy between histological activity and MPO-ANCA.
authors.affiliation: Division of Hypertension and Nephrology, National Cardiovascular Center, Suita, Japan. hnakaham@hsp.ncvc.go.jp
authors.forename: Hajime
authors.initials: H
authors.lastname: Nakahama
authors.forename: Osamu
authors.initials: O
authors.lastname: Sasaki
authors.forename: Fumiki
authors.initials: F
authors.lastname: Yoshihara
authors.forename: Satoko
authors.initials: S
authors.lastname: Nakamura
authors.forename: Takashi
authors.initials: T
authors.lastname: Inenaga
authors.forename: Yuhei
authors.initials: Y
authors.lastname: Kawano
authors.forename: Hatsue
authors.initials: H
authors.lastname: Ueda
mesh_terms: D000284:Administration, Oral; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D019268:Antibodies, Antineutrophil Cytoplasmic / Q000097:blood*; D000959:Antihypertensive Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D019808:Losartan / Q000008:administration & dosage* / Q000627:therapeutic use*; D008297:Male; D009402:Nephrosis, Lipoid / Q000097:blood* / Q000188:drug therapy* / Q000473:pathology; D017063:Outcome Assessment, Health Care; D009195:Peroxidase / Q000097:blood*; D011239:Prednisolone / Q000008:administration & dosage* / Q000627:therapeutic use*
chemical_list: D000893:Anti-Inflammatory Agents; D019268:Antibodies, Antineutrophil Cytoplasmic; D000959:Antihypertensive Agents; D011239:Prednisolone; D009195:Peroxidase; D019808:Losartan